JMP Securities Covers Mostly Good News From Pharma Pending More Visibility
JMP Bullish On Boston Scientific: 'Strong Execution and Improved Results in Core Businesses' Will Continue To Drive Growth
JMP Securities Covers Mostly Good News From Pharma Pending More Visibility
JMP Bullish On Boston Scientific: 'Strong Execution and Improved Results in Core Businesses' Will Continue To Drive Growth
UPDATE: JMP Securities Initiates Coverage On Parnell Pharmaceuticals On Compelling Investment Opportunity
JMP Securities Sets Intuitive Surgical Price Target at $700, Highest on Street
UPDATE: JMP Securities Initiates Coverage On Parnell Pharmaceuticals On Compelling Investment Opportunity
JMP Securities Sets Intuitive Surgical Price Target at $700, Highest on Street
UPDATE: JMP Securities Initiates Coverage on Qiagen NV on Multiple Positive Factors
UPDATE: JMP Securities Initiates Coverage on Quidel Awaiting Further Visibility
J.T. Haresco Recent News
UPDATE: JMP Securities Initiates Coverage on Organovo on Fair Valuation
UPDATE: JMP Securities Initiates Coverage on Laboratory Corporation of America Awaiting Better Entry Point
UPDATE: JMP Securities Initiates Coverage on Illumina on Multiple Positive Factors
UPDATE: JMP Securities Initiates Coverage on Foundation Medicine on Clear First-Mover Advantage
UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple Industry Headwinds
UPDATE: JMP Securities Initiates Coverage on Cepheid on Market Leader Position
UPDATE: JMP Securities Initiates Coverage on Alere on Multiple Positive Factors